Any of this sounds good this year...
--Reporting data from a repeat-dose nonclinical study of vepoloxamer in heart failure;
--Initiating a Phase 2 clinical study of vepoloxamer in acute decompensated heart failure;
--Initiating enrollment in an open-label EPIC extension study, referred to as EPIC-E, to expand the Company's existing safety database regarding repeat exposure to vepoloxamer;
--Reporting data from a nonclinical study of vepoloxamer in embolic stroke; and
--Reporting data from one or more of the Phase 2a studies of AIR001 in patients suffering heart failure with preserved ejection fraction (HFpEF).
Why should anyone believe you this time?
lovepipes • Nov 17, 2014 10:35 AM Flag
3users liked this postsusers disliked this posts0Reply
Going to run!!!
Well what an awesome hour of training, eh? Prepare for a big run today. They got all the shares they could get and have been adding 100's of thousands of shares at any price this am. Adam F? Yep
Or this one?
1users liked this postsusers disliked this posts2Reply
Company announcement coming today or tomorrow
by lovepipes • Nov 25, 2014 9:47 AM
A company announcement of a certain event is imminent. Today or tomorrow. Better to buy on this side of the announcement. You're welcome!!!
lovepipes • Nov 21, 2014 3:11 PM
0users liked this postsusers disliked this posts0Reply
I would like to revise my predicted close please: .75! get in now! sure looks likely.
1users liked this postsusers disliked this posts1Reply
This feels like news will be released during trading
by lovepipes • Nov 21, 2014 11:50 AM
This activity tells me something big is about to go down. They were too desperate to grab those 500k shares so quickly this am. Got tons of stop losses eaten up. I've seen this many many times. Get ready!
Sentiment: Strong Buy
I think this will be a bigger catalyst than EPIC enrollment. You'll see the price appreciate as completion of EPIC enrollment gets closer, but positive data from the heart failure study I think will be big. Good luck. From their 8K.
- During 2015, the Company also expects to: announce data from a non-clinical, repeat-dose study of vepoloxamer in heart failure and from its first nonclinical study of vepoloxamer in embolic stroke; initiate enrollment in a Phase 2 clinical study of vepoloxamer in acute decompensated heart failure; and report preliminary data from one or more Phase 2a studies of AIR001 in patients suffering heart failure with preserved ejection fraction (HFpEF).
...and you disagreed with him when? You should have just cut and pasted this post. LOL
Very hard to admit to it but DJW was right after all.
by schmark787 • Oct 23, 2014 5:36 PM Flag
DJW was warning to keep hands off MSTX and he was right after all. Maybe we should have listened to the guy instead of bashing him?!?!?!?!
That's what happens when you hit puberty. I'd advise against any pumping until they've dropped 100%. That could take a long time in your case.
djw's years of spamming this board with nonsense about other stocks are finally catching up to him. His tiny ego got bruised on the RPRX message board and he wants all of us over here at MSTX to know it.
I'm happy a company with BBs reputation has invested in this company. It is a good sign. Hope they add more, but they haven't yet.
The report date on this is 9/30/2014 so they've held these 3 million since that time at least. There are no new shares in the WSJ on page whatever like OP insinuates.
"Likely" expresses a probability. His lack of facts to back it up represents the opinion. If the post were "MSTX likely to zero" you would likely feel differently.
Doing the opposite of what pharmahero says is your best bet. He bashed ACAD for a long time when it was $1 or $2 dollars, although he may have had fewer or more r's and m's in his name then (he gets his user names banned a lot).